Health Care & Life Sciences » Pharmaceuticals | Hunan Er-Kang Pharmaceutical Co. Ltd.

Hunan Er-Kang Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,006
1,364
1,747
2,692
2,808
2,332
Cost of Goods Sold (COGS) incl. D&A
666
823
891
1,577
1,837
1,590
Gross Income
340
541
856
1,115
971
742
SG&A Expense
124
202
208
298
339
413
EBIT
214
334
642
-
629
323
Unusual Expense
-
-
2
32
7
73
Non Operating Income/Expense
-
1
15
77
38
13
Interest Expense
-
5
16
3
7
2
Pretax Income
226
337
659
862
673
290
Income Tax
32
48
60
81
76
59
Equity in Affiliates
-
1
-
-
82
21
Consolidated Net Income
194
287
599
782
515
211
Net Income
193
288
605
795
522
217
Net Income After Extraordinaries
193
288
605
795
522
217
Net Income Available to Common
193
288
605
795
522
217
EPS (Basic)
0.11
0.16
0.33
0.39
0.25
0.11
Basic Shares Outstanding
1,818
1,818
1,832
2,058
2,063
2,063
EPS (Diluted)
0.11
0.16
0.33
0.39
0.25
0.11
Diluted Shares Outstanding
1,818
1,818
1,832
2,065
2,063
2,063
EBITDA
254
408
737
911
758
452
Other Operating Expense
2
5
6
22
3
6
Non-Operating Interest Income
11
3
6
25
20
24
Minority Interest Expense
1
1
6
14
8
6

About Hunan Er-Kang Pharmaceutical Co.

View Profile
Address
Liuyang Economic & Development Zone
Changsha Hunan 410331
China
Employees -
Website http://www.hnerkang.com
Updated 07/08/2019
Hunan Er-Kang Pharmaceutical Co., Ltd. engages in the research and development, production and sale of pharmaceutical products. It offers pharmaceutical excipients, active pharmaceutical ingredients (API) and pharmaceutical preparation. The pharmaceutical excipients produce glycerol, medicinal alcohol, propylene glycol, medicinal sodium hydroxide and medical sucrose.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.